Linezolid for the treatment of patients with endocarditis: a systematic review of the published evidence | Zendy

Matthew E. Falagas | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Linezolid for the treatment of patients with endocarditis: a systematic review of the published evidence

Author(s) -

Matthew E. Falagas

Publication year - 2006

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkl219

Subject(s) - linezolid , endocarditis , antibiotics , gram positive cocci , medicine , pneumonia , antibacterial agent , intensive care medicine , microbiology and biotechnology , staphylococcus aureus , vancomycin , bacteria , biology , genetics

Linezolid is a bacteriostatic oxazolidinone antibiotic that has been proven to be effective for the treatment of patients with pneumonia, skin and soft tissue infections, and possibly bacteraemia, due to Gram-positive cocci. However, the drug is sometimes used for the treatment of patients with endocarditis due to Gram-positive cocci resistant to other antibiotics.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research